ValiRx plc (LON:VAL – Get Free Report) shares fell 12.5% on Wednesday. The company traded as low as GBX 0.14 and last traded at GBX 0.14. Approximately 324,465,531 shares were traded during mid-day trading, an increase of 2,572% from the average session volume of 12,142,369 shares. The stock had previously closed at GBX 0.16.
ValiRx Stock Performance
The company has a market cap of £1.98 million, a price-to-earnings ratio of -0.37 and a beta of 0.59. The stock’s fifty day moving average is GBX 0.14 and its two-hundred day moving average is GBX 0.18.
ValiRx (LON:VAL – Get Free Report) last released its quarterly earnings results on Tuesday, September 15th. The company reported GBX (0.09) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. On average, equities research analysts expect that ValiRx plc will post -1.74 EPS for the current year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- NextEra and Dominion Have a Deal—Now Comes the Hard Part
- Microsoft’s Earnings Problem: Even Great May Not Be Enough
- 3 Stocks With Yields Big Enough to Make Election Volatility Easier to Stomach
- Is Texas Instruments Setting Up for Its Next Big Breakout?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
